Implementing the delayed antibiotic therapy approach significantly reduced antibiotics consumption in Israeli

Zachi Grossman1, Barbara G Silverman, Boaz Porter

  • 1Pediatric Clinic, Maccabi Health Services, Tel Aviv, Israel. zgrosman@netvision.net.il

Insights

Guidelines recommending delayed antibiotic treatment for acute otitis media in children significantly reduced antibiotic use. This approach reversed a previous upward trend in prescriptions for young children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pharmacology

Background:

  • Israel Medical Association guidelines in 2004 recommended delaying antibiotic therapy for acute otitis media (AOM) in children over 6 months.
  • The guidelines suggested a 24-48 hour waiting period for non-severe AOM, with analgesics for symptom relief.

Purpose of the Study:

  • To assess the impact of the 2004 guidelines on antibiotic prescribing for AOM in Israeli children.
  • To analyze trends in antibiotic and topical therapy use for AOM before and after guideline implementation.

Main Methods:

  • Retrospective study analyzing pharmacy and physician data from 2002-2007.
  • Included children aged 6 months to 5 years with a first AOM episode, no recent antibiotic use.
  • Analyzed AOM incidence, antibiotic treatment rates, and topical pain relief rates annually.

Main Results:

  • Antibiotic treatment rates for AOM increased from 2002-2004 across all age groups (6 months-5 years).
  • Following guideline implementation (2004-2007), antibiotic treatment rates significantly decreased (P < 0.001).
  • Exclusive topical therapy use for pain relief increased significantly between 2004 and 2007 (P < 0.001).

Conclusions:

  • The delayed antibiotic treatment strategy effectively reduced antibiotic use for first-time AOM in children.
  • This approach successfully reversed a prior increasing trend in antibiotic prescriptions for AOM.
  • Implementation of delayed antibiotic therapy is a viable strategy for managing AOM in pediatric populations.
Abstract

Related Concept Videos

Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration01:23

Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration

Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
Antibiotic Selection00:57

Antibiotic Selection

Overview